Affordable Insulin Approvals Now Act
Official title: A bill to improve access to affordable insulin.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Affordable Insulin Approvals Now Act
This bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2103: Affordable Insulin Approvals Now Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-2103/
"S. 2103: Affordable Insulin Approvals Now Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2103/.
S. 2103, 116th Cong. (2026), https://openamerica.io/bill/116-S-2103/.
[S. 2103: Affordable Insulin Approvals Now Act](https://openamerica.io/bill/116-S-2103/)